Q & M Dental Group (Singapore) Limited (SGX:QC7)

Singapore · Delayed Price · Currency is SGD

0.5500

-0.0050 (-0.90%)

Jun 30, 2026, 5:11 PM SGT

23.60% (1Y)

Market Cap	520.87M +41.1%
Revenue (ttm)	197.23M +9.2%
Net Income	9.31M -34.7%
EPS	0.01 -34.7%
Shares Out	947.04M
PE Ratio	55.92
Forward PE	39.29
Dividend	0.01 (1.48%)
Ex-Dividend Date	Mar 10, 2026

Volume	511,400
Open	0.5550
Previous Close	0.5550
Day's Range	0.5450 - 0.5550
52-Week Range	0.3900 - 0.6350
Beta	0.78
Analysts	Buy
Price Target	0.66 (+20.0%)
Earnings Date	Aug 12, 2026

About SGX:QC7

Q & M Dental Group (Singapore) Limited, an investment holding company, provides private dental healthcare services in Singapore, Malaysia, and China. It offers various aesthetic/cosmetic, pediatric, CAD CAM digital, children, clear aligner, and implant dentistry services; consultation, gum disease and surgery, intraoral 3D scanning, oral surgery, root canal treatment, scaling and polishing, teeth grinding and whitening, tooth-coloured filling, and wisdom tooth surgery services; and crowns and bridges, dental X-rays and AI scan, dentures, extrac... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1996

Employees 1,135

Stock Exchange Singapore Exchange

Ticker Symbol QC7

Full Company Profile

Financial Performance

In 2025, SGX:QC7's revenue was 197.23 million, an increase of 9.16% compared to the previous year's 180.67 million. Earnings were 9.31 million, a decrease of -34.72%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for QC7 stock is "Buy." The 12-month stock price target is $0.66, which is an increase of 20.00% from the latest price.

Price Target

$0.66

(20.00% upside)

Analyst Consensus: Buy

Stock Forecasts